Figure 1.
Genomic data showing the predictability of ultra high-risk myeloma patients using genomics. (A) Arkansas model using gene expression profiling. (B) IFM model using the SNP array.
Genomic data showing the predictability of ultra high-risk myeloma patients using genomics. (A) Arkansas model using gene expression profiling. (B) IFM model using the SNP array.
